UROLOGIX INC

CIK:0000882873|SEC Filings

Condensed Statements Of Operations (USD $) In Thousands, except Per Share data, unless otherwise specified	3 Months Ended		9 Months Ended
	Mar. 31, 2015	Mar. 31, 2014	Mar. 31, 2015	Mar. 31, 2014
Condensed Statements Of Operations [Abstract]
SALES	$ 2,796us-gaap_SalesRevenueNet	$ 3,356us-gaap_SalesRevenueNet	$ 8,896us-gaap_SalesRevenueNet	$ 10,941us-gaap_SalesRevenueNet
COST OF GOODS SOLD	1,485us-gaap_CostOfRevenue	2,507us-gaap_CostOfRevenue	4,659us-gaap_CostOfRevenue	6,431us-gaap_CostOfRevenue
Gross profit	1,311us-gaap_GrossProfit	849us-gaap_GrossProfit	4,237us-gaap_GrossProfit	4,510us-gaap_GrossProfit
COSTS AND EXPENSES
Sales and marketing	657us-gaap_SellingAndMarketingExpense	1,313us-gaap_SellingAndMarketingExpense	2,196us-gaap_SellingAndMarketingExpense	4,839us-gaap_SellingAndMarketingExpense
General and administrative	449us-gaap_GeneralAndAdministrativeExpense	527us-gaap_GeneralAndAdministrativeExpense	1,404us-gaap_GeneralAndAdministrativeExpense	1,773us-gaap_GeneralAndAdministrativeExpense
Research and development	298	408	969	1,281
Change in value of acquisition consideration		(12)		(105)
Medical device tax	44ulgx_MedicalDeviceTax	52ulgx_MedicalDeviceTax	140ulgx_MedicalDeviceTax	172ulgx_MedicalDeviceTax
Amortization of identifiable intangible assets	16us-gaap_AmortizationOfIntangibleAssets	28us-gaap_AmortizationOfIntangibleAssets	56us-gaap_AmortizationOfIntangibleAssets	72us-gaap_AmortizationOfIntangibleAssets
Total costs and expenses	1,464us-gaap_OperatingExpenses	2,316us-gaap_OperatingExpenses	4,765us-gaap_OperatingExpenses	8,032us-gaap_OperatingExpenses
OPERATING LOSS	(153)us-gaap_OperatingIncomeLoss	(1,467)us-gaap_OperatingIncomeLoss	(528)us-gaap_OperatingIncomeLoss	(3,522)us-gaap_OperatingIncomeLoss
INTEREST EXPENSE	(190)us-gaap_InterestIncomeExpenseNet	(178)us-gaap_InterestIncomeExpenseNet	(594)us-gaap_InterestIncomeExpenseNet	(516)us-gaap_InterestIncomeExpenseNet
FOREIGN CURRENCY EXCHANGE (GAIN)/LOSS	(6)	(1)	(12)	1
LOSS BEFORE INCOME TAXES	(349)	(1,646)	(1,134)	(4,037)
INCOME TAX EXPENSE		18us-gaap_IncomeTaxExpenseBenefit	9us-gaap_IncomeTaxExpenseBenefit	46us-gaap_IncomeTaxExpenseBenefit
NET LOSS	$ (349)us-gaap_NetIncomeLoss	$ (1,664)us-gaap_NetIncomeLoss	$ (1,143)us-gaap_NetIncomeLoss	$ (4,083)us-gaap_NetIncomeLoss
NET LOSS PER COMMON SHARE - BASIC	$ (0.02)us-gaap_EarningsPerShareBasic	$ (0.08)us-gaap_EarningsPerShareBasic	$ (0.05)us-gaap_EarningsPerShareBasic	$ (0.19)us-gaap_EarningsPerShareBasic
NET LOSS PER COMMON SHARE - DILUTED	$ (0.02)us-gaap_EarningsPerShareDiluted	$ (0.08)us-gaap_EarningsPerShareDiluted	$ (0.05)us-gaap_EarningsPerShareDiluted	$ (0.19)us-gaap_EarningsPerShareDiluted
WEIGHTED AVERAGE NUMBER OF COMMON SHARES OUTSTANDING - BASIC	21,838	21,326	21,701	21,195
WEIGHTED AVERAGE NUMBER OF COMMON SHARES OUTSTANDING - DILUTED	21,838	21,326	21,701	21,195

Condensed Statements Of Cash Flows (USD $)
In Thousands, unless otherwise specified

9 Months Ended

Mar. 31, 2015

Mar. 31, 2014

OPERATING ACTIVITIES

Net loss

$ (1,143)

$ (4,083)

Adjustments to reconcile net loss to net cash used for operating activities:

Depreciation and amortization

361

447

Employee stock-based compensation expense

169

Provision for bad debts

(7)

Prostiva inventory reserve

739

Loss on disposal of assets

Accretion expense on deferred acquisition payments

387

334

Net adjustment to acquisition consideration

(105)

Deferred income taxes

Change in operating assets and liabilities:

Prepaids and other assets

Other accrued expenses

Net cash used for operating activities

(172)

(1,439)

INVESTING ACTIVITIES

Purchases of property and equipment

(8)

(28)

Purchases of intellectual property

(15)

(7)

Proceeds from sale of property and equipment

Cash restricted for collateral

(40)

Net cash used for investing activities

CASH

^[1]

Supplemental cash-flow information

Income taxes paid during the period

Net carrying amount of inventory transferred to property and equipment

$ 25

$ 46

[1]	The Balance Sheet at June 30, 2014 has been derived from the audited financial statements at that date but does not include all of the information and footnotes required by generally accepted accounting principles for complete financial statements.

Condensed Balance Sheets (USD $)
In Thousands, unless otherwise specified

Mar. 31, 2015

Jun. 30, 2014

Current Assets:

^[1]

Accounts receivable, net of allowance of $46 and $76, respectively

^[1]

^[1]

Prepaids and other current assets

^[1]

^[1]

Property and equipment:

Property and equipment

12,144

12,162

^[1]

Less accumulated depreciation

(11,853)

(11,691)

^[1]

Property and equipment, net

291

471

^[1]

Other intangible assets, net

1,230

1,370

^[1]

Long-term inventories

^[1]

^[1]

^[1]

Current liabilities:

^[1]

^[1]

Short-term deferred acquisition payment

2,044

1,339

^[1]

Current portion of long-term debt (Note 12)

^[1]

^[1]

Other accrued expenses

577

505

^[1]

Total current liabilities

6,129

4,292

^[1]

Long-term deferred acquisition payment

3,412

3,730

^[1]

Long-term debt (Note 12)

3,537

4,586

^[1]

Other accrued expenses

^[1]

Total liabilities

13,086

12,644

^[1]

Commitments and Contingencies (Note 13)

^[1]

SHAREHOLDERS' DEFICIT:

Common stock, $.01 par value, 30,000 shares authorized; 21,818 and 21,291 shares issued; and 21,282 and 20,945 shares outstanding

213

209

^[1]

Additional paid-in capital

^[1]

^[1]

Total shareholders' deficit

(8,063)

(6,977)

^[1]

Total liabilities and shareholders' deficit

$ 5,023

$ 5,667

^[1]

[1]	The Balance Sheet at June 30, 2014 has been derived from the audited financial statements at that date but does not include all of the information and footnotes required by generally accepted accounting principles for complete financial statements.